New share issue in Biotage AB (SE) — SEK 97 million Healthcare New share issue in Biotage AB (SE) — SEK 97 million
Directed new share issue in BioInvent International (SE) — SEK 136 million Healthcare Directed new share issue in BioInvent International (SE) — SEK 136 million
Divestment of Telia’s (SE) commercial property portfolio — SEK 5.1 billion Real Estate Divestment of Telia’s (SE) commercial property portfolio — SEK 5.1 billion
Secondary placing of 10.85 million shares in NCC (SE) — SEK 1.2 billion Real Estate Secondary placing of 10.85 million shares in NCC (SE) — SEK 1.2 billion
Secondary placing of 5.7 million shares in Intrum Justitia (SE) — EUR 35 million FIG Secondary placing of 5.7 million shares in Intrum Justitia (SE) — EUR 35 million
Convertible rights issue in Elekta (SE) — SEK 467 million Healthcare Convertible rights issue in Elekta (SE) — SEK 467 million
Initial public offering of BioInvent International AB (SE) — SEK 372 million Healthcare Initial public offering of BioInvent International AB (SE) — SEK 372 million
Divestment of Entific Medical Systems (SE) to Cochlear (AU) by CapMan, Investor Growth Capital and Nobel Biocare (SE) — SEK 1,050 million Healthcare Divestment of Entific Medical Systems (SE) to Cochlear (AU) by CapMan, Investor Growth Capital and Nobel Biocare (SE) — SEK 1,050 million
New share issue in Biotage AB (SE) — SEK 34 million Healthcare New share issue in Biotage AB (SE) — SEK 34 million
Directed new share issue in Oasmia Pharmaceutical AB (SE) — SEK 48 million Healthcare Directed new share issue in Oasmia Pharmaceutical AB (SE) — SEK 48 million
Redemption in Castellum (SE) — SEK 700 million Real Estate Redemption in Castellum (SE) — SEK 700 million
Placing of shares in FastPartner (SE) — SEK 125 million Real Estate Placing of shares in FastPartner (SE) — SEK 125 million